期刊文献+

重型和中间型β-地中海贫血患儿输注洗涤红细胞的效果比较 被引量:8

A Comparative Investigation of the Therapuetic Effect in Children with β-thalassemia and Received Transfusion of Washed Erythrocytes
下载PDF
导出
摘要 目的分析重型和中间型β-地中海贫血患者输注洗涤红细胞后疗效的差别.方法选取两型患儿共23例,在输血背景相同的条件下,调查相同年龄阶段( 3-4岁)两组各21例次输注洗涤红细胞前后的血红蛋白水平,比较两型患儿输 血后血红蛋白增量的差异,以及是否发生输血不良反应.结果42例次输血均未发生输血不良反应,同年龄阶段重型β-地中海贫血患儿每输1 U洗涤红细胞后每千克体重血红蛋白增量较中间型地贫患儿相比偏低(P〈0.05 ).结论在同年龄阶段输 注同量的洗涤红细胞,重型β-地中海贫血患者由于其病情相对较重,导致Hb提升水平比中间型患者低,同时临床在应用洗 涤红细胞时应确保达到目标Hb水平和安全输血双重目标的实现. Objective To analyze the effect of washed red blood cells(wRBC) transfusion in treatment of children with severe or intermediate β-thalassemia. Methods Twenty-three children at the age of 3?4 were selected and all of them had the same blood transfusion experience. Hemoglobin levels were tested in the children who sufferred from severe or moderatep-thalassemia and underwent 21 times of blood transfusion with wRBC in each type of disease. and frequency of adverse effects of transfusion was observed. Results All the children investgated showed no adverse transfusion reaction. Children with severe type of β-thalassemia exhibited a lower increase of hemoglobin [ (1.62 ± 0.26) g/L per kg] than those with moderate type of the disease[ (1.17 ± 0.23) g/L per kg] after use of one unit of wRBC (P〈0.05 ) . Conclusion Hemoglobin level improvement in the children with severe type of β-thalassemia is not remarkable when compared with those who have moderate type of the disease after wRBC transfusion. Clinically, a relative high level of hemoglobin, and transfusion safety as well, should be ensured during wRBC transfusion.
出处 《临床输血与检验》 CAS 2016年第5期446-448,共3页 Journal of Clinical Transfusion and Laboratory Medicine
关键词 Β-地中海贫血 输血 洗涤红细胞 β-thalassemia Blood transfusion Washed red blood cell
  • 相关文献

参考文献3

二级参考文献67

  • 1张锁柱,贾少荣,高风英.白细胞过滤器在临床输血中的应用[J].内蒙古医学杂志,2006,38(2):125-127. 被引量:9
  • 2Angastiniotis M, Modell B. Global epidemiology of hemoglobin disorders. Ann N Y Acad Sci, 1998, 850:251-259.
  • 3Viehinsky EP. Changing patterns of thalassemia worldwide. Ann N Y Aead Sei, 2005,1054 : 18-24.
  • 4National Co-ordination Group of Haemoglobinopathy Research. A survey of haemoglobinopathy in 600,000 people of 20 provinces, cities and autonomous regions of China. National Med J Chin, 1983,63:382-385.
  • 5Forget BG, Cohen AR. Thalassemia syndromes// Hoffman R, Benz E J, Shattil SS, et al. Hematology: Basic Principles and Practice. 4th ed. Philadelphia, Pa : Elsevier Churchill Livingstone,2005,35 : 485-509.
  • 6Debaun MR, Vichinsky E. Hemoglobinopathies//Kliegman RM, Behnnan RE, Jenson HB, et al. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, Pa: Saunders Elsevier,2007, 462:2025- 2038.
  • 7Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med,2005, 353 : 1135-1146.
  • 8Gu X, Zeng Y. A review of the molecular diagnosis of thalassemia. Hematology,2002,7 : 203-209.
  • 9Deng J, Peng WL, Li J, et al. Successful preimplantation genetic diagnosis for alpha- and beta-thalassemia in China. Prenat Diagn, 2006, 26 : 1021-1028.
  • 10Cazzola M, DeStrfano P, Ponehio L, et al. Relationship between transfusion regimen and suppression of erythropoiesis in beta- thalassaemia major. BrJ Haematol,1995 ,89 :473-478.

共引文献109

同被引文献82

引证文献8

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部